US 7825242
Dipeptidyl peptidase inhibitors
granted A61PA61P13/12A61P17/06
Quick answer
US patent 7825242 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P13/12, A61P17/06, A61P25/00, A61P29/00